Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 1999

View Archived Issues

U.S. patent granted for conjugate vaccine against group B streptococci

Nortran and Roche terminate arrhythmia collaboration

BioChem Pharma moves towards integration, buys back shares from Glaxo Wellcome

Solvay to acquire Unimed

Novopharm Biotech's fully human antibody vaccine enters clinical trials

Medco's imaging adjunct completes phase I trial

Intrathecal morphine administration via implantable pump in the treatment of chronic pain

European hypertension news: efficacy of beta-blocker talinolol in hypertensive patients

Hepatoprotective agents in development at Korean labs

Cerebrus presents dual antioxidant/iron-chelating agents for stroke

RPR research group prepares new cell adhesion inhibitors especially useful in asthma

Mechanism of action of AGN-192403 determined in rabbit model

New tyrosine kinase inhibitor series presented by Pfizer

Search for new anticonvulsants with affinity for novel binding site continues at SB

BioCryst reports progress in the search for novel flu treatments

New series from American Home Products elevates HDL cholesterol

Two research teams reach the same conclusion: topiramate is a promising antimigraine agent

Fujisawa develops antiinflammatory agents acting on cyclooxygenase

Pfizer's new substance P antagonists particularly useful as antiemetics

Selective M1 receptor agonist chosen for further study under Novo Nordisk/Lilly collaboration

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

Botox is not effective in treating whiplash injury

Chiroscience completes worldwide marketing agreements for Chirocaine

Safety and pharmacokinetic data presented for almotriptan at Boston headache meeting

News from ENDO '99: Sensus's treatment for acromegaly excels in phase II and III trials

Campylobacter vaccine completes phase II trial

Pericranial botulinum toxin assessed in various types of migraine

Active Biotech and Oxigene enter inflammatory disease collaboration

Transdermal testosterone as a treatment for female sexual dysfunction

Phase II results of Fibrimage presented at Society of Nuclear Medicine meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...